Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, Phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 11 | 0 | 0 | 11 |
Chain A, Class I phosphodiesterase PDEB1 | 0 | 1 | 0 | 1 |
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 10 | 0 | 0 | 10 |
thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
estrogen-related nuclear receptor alpha | 39 | 0 | 0 | 39 |
Phosphodiesterase | 0 | 4 | 0 | 4 |
mitogen-activated protein kinase 1 | 9 | 0 | 0 | 9 |
geminin | 41 | 0 | 0 | 41 |
cytochrome P450 3A4 isoform 1 | 16 | 0 | 0 | 16 |
histone acetyltransferase KAT2A isoform 1 | 12 | 0 | 0 | 12 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 16 | 4 | 2 | 22 |
Monocarboxylate transporter 4 | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Renin | 0 | 4 | 0 | 4 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit delta | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 16 | 5 | 2 | 23 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 16 | 4 | 2 | 22 |
Adenosine receptor A1 | 0 | 5 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 16 | 4 | 2 | 22 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 11 | 3 | 16 |
Adenosine receptor A2b | 0 | 1 | 0 | 3 |
Adenosine receptor A2b | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 16 | 4 | 2 | 22 |
Adenosine receptor A1 | 0 | 10 | 3 | 17 |
Adenosine receptor A2a | 0 | 5 | 0 | 8 |
Sodium-dependent serotonin transporter | 0 | 5 | 0 | 5 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit beta-3 | 16 | 4 | 2 | 22 |
Gamma-aminobutyric acid receptor subunit beta-2 | 16 | 4 | 2 | 22 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 8 | 0 | 9 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 3 | 0 | 3 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
GABA theta subunit | 16 | 4 | 2 | 22 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 16 | 4 | 2 | 22 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 22 | 0 | 0 | 22 |
thyroid stimulating hormone receptor | 13 | 0 | 0 | 13 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 10 | 0 | 0 | 10 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 4 | 0 | 4 |
thioredoxin reductase | 21 | 0 | 0 | 21 |
GALC protein | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 30 | 0 | 0 | 30 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 21 | 0 | 0 | 21 |
glucocorticoid receptor [Homo sapiens] | 38 | 0 | 0 | 38 |
retinoic acid nuclear receptor alpha variant 1 | 32 | 0 | 0 | 32 |
retinoid X nuclear receptor alpha | 26 | 0 | 0 | 26 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
arylsulfatase A | 14 | 0 | 0 | 14 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 39 | 0 | 0 | 39 |
Bloom syndrome protein isoform 1 | 10 | 0 | 0 | 10 |
thyroid hormone receptor beta isoform a | 17 | 0 | 0 | 17 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 34 | 0 | 0 | 34 |
peripheral myelin protein 22 | 25 | 0 | 0 | 25 |
survival motor neuron protein isoform d | 15 | 0 | 0 | 15 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 27 | 0 | 27 |
Multidrug resistance-associated protein 4 | 0 | 28 | 0 | 30 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 9 | 0 | 9 |
Carbonic anhydrase 12 | 0 | 7 | 1 | 13 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 41 | 0 | 41 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 16 | 1 | 25 |
Carbonic anhydrase 2 | 0 | 19 | 2 | 28 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 3 | 1 | 5 |
Carbonic anhydrase 3 | 0 | 6 | 1 | 10 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 12 | 1 | 16 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 7 | 2 | 9 |
Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 14 | 0 | 15 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
Androgen receptor | 0 | 15 | 1 | 17 |
Translocator protein | 0 | 1 | 2 | 3 |
Cannabinoid receptor 1 | 0 | 3 | 2 | 5 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 4 | 0 | 11 | 1 | 16 |
Carbonic anhydrase 6 | 0 | 7 | 1 | 12 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Endochitinase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
Delta-type opioid receptor | 0 | 3 | 0 | 4 |
Cytochrome P450 2C19 | 0 | 6 | 0 | 6 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Mu-type opioid receptor | 0 | 6 | 1 | 10 |
Carbonic anhydrase 5A, mitochondrial | 0 | 8 | 1 | 14 |
Carbonic anhydrase | 0 | 8 | 0 | 9 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
Carbonic anhydrase 7 | 0 | 7 | 1 | 12 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 3 | 1 | 0 | 4 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
D(2) dopamine receptor | 0 | 5 | 0 | 6 |
Cholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 5 | 0 | 5 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 2 | 8 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 10 | 2 | 17 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 27 | 0 | 27 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 5 | 0 | 7 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 7 | 0 | 11 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase 14 | 0 | 6 | 1 | 12 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 8 | 1 | 14 |
Luciferase | 9 | 0 | 0 | 9 |
USP1 protein, partial | 20 | 0 | 0 | 20 |
TDP1 protein | 32 | 0 | 0 | 32 |
Microtubule-associated protein tau | 14 | 0 | 0 | 14 |
AR protein | 39 | 0 | 0 | 39 |
aldehyde dehydrogenase 1 family, member A1 | 22 | 0 | 0 | 22 |
estrogen nuclear receptor alpha | 47 | 0 | 0 | 47 |
peroxisome proliferator activated receptor gamma | 21 | 0 | 0 | 21 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 20 | 0 | 0 | 20 |
vitamin D3 receptor isoform VDRA | 15 | 0 | 0 | 15 |
thyroid hormone receptor beta isoform 2 | 24 | 0 | 0 | 24 |
flap endonuclease 1 | 6 | 0 | 0 | 6 |
serine/threonine-protein kinase PLK1 | 4 | 0 | 0 | 4 |
eyes absent homolog 2 isoform a | 3 | 0 | 0 | 3 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 14 | 0 | 14 |
Rap guanine nucleotide exchange factor 3 | 6 | 0 | 0 | 6 |
Cellular tumor antigen p53 | 27 | 0 | 0 | 27 |
Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 12 | 0 | 0 | 12 |
HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 2 | 2 |
ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
Heat shock protein HSP 90-beta | 0 | 1 | 1 | 3 |
2-dehydropantoate 2-reductase | 0 | 2 | 4 | 6 |
Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
Endoplasmin | 0 | 0 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 11 | 3 | 15 |
Delta-type opioid receptor | 0 | 9 | 3 | 13 |
Kappa-type opioid receptor | 0 | 11 | 3 | 15 |
Endoplasmin | 0 | 1 | 1 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 2 | 2 |
P2Y purinoceptor 1 | 0 | 0 | 2 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 0 | 1 | 1 |
Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 1 | 2 |
Chain A, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
Chain B, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
Chain A, ADP-dependent glucokinase | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, phosphodiesterase-nucleotide pyrophosphatase | 0 | 1 | 0 | 1 |
Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
Chain B, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 27 | 0 | 0 | 27 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 19 | 0 | 0 | 19 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 1 | 2 |
Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 1 | 2 |
Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 3 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 0 | 0 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 2 |
GTP:AMP phosphotransferase AK3, mitochondrial | 0 | 0 | 0 | 1 |
Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 2 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 3 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 2 |
Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
Glycine--tRNA ligase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 3 |
Adenosine deaminase-like protein | 0 | 0 | 0 | 1 |
Protease | 0 | 1 | 1 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 1 | 2 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 2 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 2 | 3 |
ATP-dependent phosphofructokinase | 15 | 0 | 0 | 15 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
Sex hormone-binding globulin | 0 | 1 | 4 | 5 |
Corticosteroid-binding globulin | 0 | 4 | 0 | 4 |
Mineralocorticoid receptor | 0 | 6 | 4 | 11 |
Mineralocorticoid receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 3 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
Thromboxane-A synthase | 0 | 4 | 0 | 4 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 3 | 2 | 5 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 18 | 0 | 0 | 18 |
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
acetylcholinesterase | 12 | 0 | 0 | 12 |
glucocerebrosidase | 5 | 0 | 0 | 5 |
alpha-galactosidase | 6 | 0 | 0 | 6 |
cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 24 | 0 | 0 | 24 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 10 | 0 | 11 |
Prothrombin | 0 | 1 | 1 | 2 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Plasminogen | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
Cationic trypsin | 0 | 1 | 0 | 1 |
Coagulation factor XI | 0 | 1 | 0 | 1 |
Plasma kallikrein | 0 | 2 | 0 | 3 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Trypsin-1 | 0 | 1 | 0 | 1 |
Trypsin-2 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 3 | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 1 | 0 | 1 |
Amiloride-sensitive sodium channel subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
Sodium/hydrogen exchanger 2 | 0 | 2 | 0 | 2 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 12 | 0 | 12 |
Sodium channel protein type 5 subunit alpha | 0 | 6 | 0 | 6 |
Sodium/hydrogen exchanger 5 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 2 | 0 | 6 | 0 | 6 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 3 | 3 | 6 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
phosphopantetheinyl transferase | 14 | 0 | 0 | 14 |
NFKB1 protein, partial | 8 | 0 | 0 | 8 |
GLS protein | 11 | 0 | 0 | 11 |
chromobox protein homolog 1 | 21 | 0 | 0 | 21 |
DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
muscarinic acetylcholine receptor M1 | 12 | 0 | 0 | 12 |
lethal factor (plasmid) | 8 | 0 | 0 | 8 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 2 | 1 | 4 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 0 | 3 | 3 |
Vasopressin V1a receptor | 0 | 4 | 2 | 6 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
ATAD5 protein, partial | 6 | 0 | 0 | 6 |
vasopressin V1b receptor | 1 | 0 | 0 | 1 |
cAMP-dependent protein kinase type I-alpha regulatory subunit | 0 | 0 | 1 | 1 |
cAMP-dependent protein kinase type II-beta regulatory subunit | 0 | 0 | 1 | 1 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
cAMP-dependent protein kinase catalytic subunit beta isoform 1 | 0 | 0 | 1 | 1 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
relaxin receptor 1 isoform 1 | 2 | 0 | 0 | 2 |
relaxin receptor 2 isoform 1 | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 5 | 0 | 0 | 5 |
cAMP-dependent protein kinase catalytic subunit beta isoform 3 | 0 | 0 | 1 | 1 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
PPM1D protein | 6 | 0 | 0 | 6 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
nuclear receptor ROR-gamma isoform 1 | 10 | 0 | 0 | 10 |
Interferon beta | 20 | 0 | 0 | 20 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 8 | 3 | 13 |
Vitamin D3 receptor | 0 | 2 | 3 | 9 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 3 | 3 |
Vitamin D3 receptor | 0 | 0 | 2 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 1 | 0 | 1 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 6 | 0 | 0 | 6 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
SMAD family member 2 | 4 | 0 | 0 | 4 |
SMAD family member 3 | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 9 | 0 | 0 | 9 |
progesterone receptor | 21 | 0 | 0 | 21 |
farnesoid X nuclear receptor | 18 | 0 | 0 | 18 |
pregnane X nuclear receptor | 25 | 0 | 0 | 25 |
G | 17 | 0 | 0 | 17 |
bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
peroxisome proliferator-activated receptor delta | 14 | 0 | 0 | 14 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 22 | 0 | 0 | 22 |
activating transcription factor 6 | 10 | 0 | 0 | 10 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 11 | 0 | 0 | 11 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
transcriptional regulator ERG isoform 3 | 7 | 0 | 0 | 7 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
snurportin-1 | 3 | 0 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 15 | 0 | 0 | 15 |
HLA class I histocompatibility antigen, B alpha chain | 17 | 0 | 0 | 17 |
Glucocorticoid receptor | 0 | 13 | 3 | 22 |
Glycine receptor subunit alpha-1 | 0 | 12 | 0 | 12 |
Glutamate receptor 2 | 15 | 0 | 0 | 15 |
Glycine receptor subunit beta | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-2 | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-3 | 0 | 12 | 0 | 12 |
Spike glycoprotein | 10 | 1 | 2 | 13 |
Inositol hexakisphosphate kinase 1 | 17 | 0 | 0 | 17 |
cytochrome P450 2C9, partial | 17 | 0 | 0 | 17 |
EWS/FLI fusion protein | 11 | 0 | 0 | 11 |
nonstructural protein 1 | 5 | 0 | 0 | 5 |
ORF73 | 0 | 0 | 1 | 1 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
Fumarate hydratase | 6 | 0 | 0 | 6 |
Thrombopoietin | 3 | 0 | 0 | 3 |
Smad3 | 6 | 0 | 0 | 6 |
caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 16 | 0 | 0 | 16 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 | 15 | 0 | 0 | 15 |
polyprotein | 6 | 0 | 0 | 6 |
67.9K protein | 8 | 0 | 0 | 8 |
Snq2p | 0 | 0 | 0 | 1 |
caspase-3 | 4 | 0 | 0 | 4 |
IDH1 | 11 | 0 | 0 | 11 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Histone H2A.x | 12 | 0 | 0 | 12 |
Caspase-7 | 3 | 0 | 0 | 3 |
Spike glycoprotein | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
cellular tumor antigen p53 isoform a | 7 | 0 | 0 | 7 |
D(1A) dopamine receptor | 6 | 0 | 0 | 6 |
potassium voltage-gated channel subfamily H member 2 isoform d | 6 | 0 | 0 | 6 |
caspase-3 | 3 | 0 | 0 | 3 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 11 | 0 | 0 | 11 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
M-phase phosphoprotein 8 | 7 | 0 | 0 | 7 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 6 | 0 | 0 | 6 |
Transmembrane protease serine 2 | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 4 | 0 | 12 | 0 | 12 |
Potassium channel subfamily K member 2 | 0 | 1 | 3 | 4 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Albumin | 0 | 7 | 3 | 10 |
Albumin | 0 | 0 | 3 | 3 |
Major prion protein | 0 | 0 | 1 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Integrin beta-3 | 5 | 0 | 0 | 5 |
Tyrosine-protein kinase Fyn | 0 | 4 | 0 | 4 |
Procathepsin L | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 11 | 0 | 11 |
Muscarinic acetylcholine receptor M2 | 0 | 6 | 1 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 5 |
ATP-dependent translocase ABCB1 | 0 | 11 | 1 | 13 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 5 | 0 | 0 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 5 | 2 | 7 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 5 |
Alpha-2A adrenergic receptor | 0 | 11 | 3 | 16 |
Replicase polyprotein 1a | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 2 | 1 | 3 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 7 | 1 | 9 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 7 | 0 | 7 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 10 | 1 | 12 |
Alpha-1B adrenergic receptor | 0 | 17 | 1 | 18 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 6 | 1 | 9 |
Alpha-2C adrenergic receptor | 0 | 5 | 2 | 9 |
D | 0 | 3 | 0 | 3 |
D(3) dopamine receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 10 | 1 | 12 |
Alpha-2B adrenergic receptor | 0 | 5 | 2 | 7 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 7 | 1 | 9 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 6 | 0 | 6 |
D(1A) dopamine receptor | 0 | 8 | 1 | 10 |
D(4) dopamine receptor | 0 | 5 | 0 | 6 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 5 | 2 | 7 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 5 | 2 | 7 |
Alpha-1D adrenergic receptor | 0 | 7 | 1 | 8 |
Sodium-dependent noradrenaline transporter | 0 | 10 | 0 | 10 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 6 | 0 | 6 |
Alpha-1D adrenergic receptor | 0 | 6 | 2 | 10 |
D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 1 | 3 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 10 | 1 | 11 |
5-hydroxytryptamine receptor 2C | 0 | 13 | 1 | 14 |
5-hydroxytryptamine receptor 1B | 0 | 9 | 0 | 9 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Sodium-dependent serotonin transporter | 0 | 12 | 0 | 12 |
Melanocortin receptor 4 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 4 | 0 | 4 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 2 | 7 |
D(3) dopamine receptor | 0 | 9 | 0 | 10 |
Sodium channel protein type 1 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 4 subunit alpha | 0 | 4 | 0 | 5 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 12 | 1 | 13 |
Melanocortin receptor 3 | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 17 | 1 | 18 |
Histamine H2 receptor | 8 | 2 | 2 | 12 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 10 | 1 | 11 |
Cytochrome P450 2J2 | 0 | 8 | 0 | 8 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
Calmodulin | 0 | 1 | 1 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 2 | 7 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 2 | 7 |
Sodium channel protein type 7 subunit alpha | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 5 |
Sodium-dependent dopamine transporter | 0 | 10 | 0 | 10 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 2 | 7 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 2 | 7 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 5 | 0 | 5 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Ataxin-2 | 8 | 0 | 0 | 8 |
Sigma non-opioid intracellular receptor 1 | 0 | 8 | 0 | 8 |
Angiotensin-converting enzyme 2 | 0 | 2 | 2 | 4 |
Sodium channel protein type 3 subunit alpha | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 2 | 7 |
Sodium channel protein type 11 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 8 subunit alpha | 0 | 3 | 0 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 3 | 0 | 3 |
aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
Lanosterol 14-alpha demethylase | 0 | 3 | 0 | 3 |
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
interleukin 8 | 5 | 0 | 0 | 5 |
15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 3 | 3 |
Nuclear receptor ROR-gamma | 10 | 0 | 0 | 10 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 4 | 0 | 5 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 5 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 6 | 0 | 8 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 3 | 0 | 4 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 4 | 0 | 4 |
PINK1 | 1 | 0 | 0 | 1 |
Parkin | 3 | 0 | 0 | 3 |
Extracellular calcium-sensing receptor | 0 | 0 | 1 | 1 |
pregnane X receptor | 8 | 0 | 0 | 8 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 2 | 3 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 0 | 1 | 1 |
Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
Adenylate cyclase type 1 | 0 | 1 | 1 | 3 |
ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
Relaxin receptor 1 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
C-8 sterol isomerase | 0 | 2 | 0 | 2 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 1 | 4 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 10 | 4 | 15 |
Beta-1 adrenergic receptor | 0 | 10 | 3 | 13 |
Adenosine receptor A3 | 0 | 12 | 1 | 13 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Alpha-synuclein | 2 | 1 | 0 | 3 |
Estrogen-related receptor gamma | 0 | 1 | 1 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 1 | 0 | 2 |
TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 8 | 4 | 12 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 0 | 4 |
Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 6 | 2 | 9 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 2 |
Androgen receptor | 0 | 1 | 1 | 2 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 1 | 2 |
Cannabinoid receptor 2 | 0 | 1 | 1 | 2 |
G-protein coupled bile acid receptor 1 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 2 | 0 | 2 |
Eyes absent homolog 2 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Vpr | 3 | 0 | 0 | 3 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 0 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 4 | 0 | 5 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 5 | 0 | 0 | 5 |
Type IV secretion-like conjugative transfer relaxase protein TraI | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Beta-galactosidase | 0 | 1 | 0 | 1 |
Lipopolysaccharide heptosyltransferase 1 | 0 | 1 | 0 | 1 |
PA-I galactophilic lectin | 0 | 0 | 1 | 1 |
Jacalin | 0 | 0 | 1 | 1 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
Asc-type amino acid transporter 1 | 0 | 2 | 0 | 2 |
Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Amino acid transporter | 0 | 2 | 0 | 2 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Chain A, Probable hydrogenase nickel incorporation protein hypB | 0 | 0 | 1 | 1 |
Chain B, Probable hydrogenase nickel incorporation protein hypB | 0 | 0 | 1 | 1 |
Chain A, ELONGATION FACTOR TU (EF-TU) | 0 | 0 | 1 | 1 |
Chain A, Elongation Factor G | 0 | 0 | 1 | 1 |
Chain A, ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 3 | 0 | 0 | 1 | 1 |
Chain A, Eukaryotic peptide chain release factor GTP-binding subunit | 0 | 0 | 1 | 1 |
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b | 0 | 0 | 2 | 2 |
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b | 0 | 0 | 2 | 2 |
Chain A, interferon-inducible GTPase | 0 | 0 | 1 | 1 |
Chain A, interferon-inducible GTPase | 0 | 0 | 1 | 1 |
Chain A, Elongation factor 2 | 0 | 0 | 1 | 1 |
Chain A, Guanine nucleotide-binding protein G(i), alpha-1 subunit | 0 | 0 | 1 | 1 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Matrilysin | 0 | 1 | 0 | 1 |
Ras-related protein Rab-7a | 0 | 0 | 2 | 2 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 | 0 | 1 | 0 | 1 |
Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 | 0 | 4 | 0 | 4 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
Chain B, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
Chain C, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
Protein-glutamine gamma-glutamyltransferase 2 | 0 | 1 | 0 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 0 | 1 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Prostaglandin D2 receptor | 0 | 0 | 1 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 2 | 5 |
beta-2 adrenergic receptor | 3 | 0 | 0 | 3 |
hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
glucokinase regulatory protein | 2 | 0 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 6 | 4 | 11 |
Beta-2 adrenergic receptor | 0 | 4 | 1 | 7 |
Beta-3 adrenergic receptor | 0 | 7 | 3 | 10 |
Beta-1 adrenergic receptor | 0 | 4 | 2 | 9 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1A adrenergic receptor | 0 | 1 | 3 | 6 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 4 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 3 | 7 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
Polyphenol oxidase 2 | 0 | 3 | 0 | 6 |
Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
Tyrosinase | 0 | 1 | 0 | 1 |
SLC16A10 protein | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
Fatty acid synthase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 1 | 5 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 2 | 2 | 4 |
Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 0 | 1 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 1 | 2 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
endonuclease IV | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 4 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Pannexin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 12 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Pannexin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 2 | 0 | 3 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 1 | 1 | 2 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Orexin receptor type 1 | 0 | 0 | 0 | 1 |
Cathepsin B | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 2 | 8 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 2 | 1 | 6 |
Cannabinoid receptor 1 | 0 | 3 | 1 | 4 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
N-arachidonyl glycine receptor | 0 | 1 | 0 | 1 |
G-protein coupled receptor 55 | 0 | 0 | 1 | 1 |
Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
Chain A, CES1 protein | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 2 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Protein kinase C iota type | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 2 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 3 | 0 | 3 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Protein cereblon | 0 | 2 | 1 | 4 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
Transthyretin | 0 | 1 | 0 | 3 |
Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 4 | 4 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 2 |
chaperonin GroEL | 1 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Tissue factor | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |